ALBERT DAVID
Back to Balance Sheet
|
ALBERT DAVID Last 5 Year Total Non-Current Liabilities History
[Standalone]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹15 Cr | ₹16 Cr | ₹12 Cr | ₹14 Cr | ₹26 Cr |
What is the latest Total Non-Current Liabilities ratio of ALBERT DAVID ?
Year | Total Non-Current Liabilities |
---|---|
Mar2025 | ₹15 Cr |
Mar2024 | ₹16 Cr |
Mar2023 | ₹12 Cr |
Mar2022 | ₹14 Cr |
Mar2021 | ₹26 Cr |
How is Total Non-Current Liabilities of ALBERT DAVID Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹15 Cr | -7.59 | |
Mar2024 | ₹16 Cr | 34.17 | |
Mar2023 | ₹12 Cr | -17.53 | |
Mar2022 | ₹14 Cr | -43.56 | |
Mar2021 | ₹26 Cr | - |
Compare Total Non-Current Liabilities of peers of ALBERT DAVID
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALBERT DAVID | ₹515.4 Cr | -1.9% | 5.5% | -31.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,289.0 Cr | -0.4% | -0.9% | 4.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,397.0 Cr | -0.7% | 1.6% | 50.2% | Stock Analytics | |
CIPLA | ₹119,955.0 Cr | -1.7% | -1.1% | -2.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,132.0 Cr | -1.1% | 1.6% | 13.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,657.0 Cr | -4.3% | -8% | -4.4% | Stock Analytics |
ALBERT DAVID Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALBERT DAVID | -1.9% |
5.5% |
-31.9% |
SENSEX | -1.1% |
-0% |
3.2% |
You may also like the below Video Courses